The Rojas Report

Rojas Media

The Rojas Report with Dutch Rojas cuts through the noise in American healthcare. From policy fights in Washington to the boardrooms of venture-backed startups, Dutch brings physicians, investors, and entrepreneurs into real conversations about money, power, and independence in medicine.Expect sharp takes on healthcare policy, candid talks with startup founders, and even the occasional cigar-fueled debate about where the system is headed next.If you care about the future of healthcare, and who really gets to shape it, this is your show.

  1. FEB 4

    Dutch Rojas on the $825 Million Hospital Deal That Trapped Oklahoma Taxpayers

    HCA wanted out. SSM spent six months on due diligence and walked away without making an offer. Then the state of Oklahoma intervened and paid 10% above the asking price. This episode breaks down the OU Health transaction: how the purchase price increased by $75 million between court approval and closing, why Moody's downgraded the system to junk status, and how $1.5 billion in debt now rests on Oklahoma taxpayers. The pattern isn't unique to Oklahoma. University of Michigan, Banner Health in Arizona, Vanderbilt in Tennessee. Public entities continue to acquire hospitals that private operators are desperate to sell. The question nobody asks: If the smartest money in healthcare is selling, why is your government buying? In this episode: The HCA signal: what it means when for-profit operators exit a marketSSM's six-month due diligence and silent walkawayThe mysterious $75 million price increase with no documented court approvalHow 340B and Medicaid supplemental payments became the new business modelMoody's B3 downgrade and what "junk status" actually costsWhy legislators are now talking about "bailing out" their own purchaseThe national pattern: Michigan, Arizona, Tennessee, and beyondWhen HCA loses money, shareholders bear the brunt of the loss. When OU Health loses money, you pay. Subscribe to The Rojas Report: dutchrojas.substack.com 60,000+ physicians and healthcare operators read it daily. Support the show If you want to support these efforts, Buy Dutch a Cigar, connect via socials, or collaborate, visit: 👉 Stan.Store/DutchRojas

    15 min
  2. FEB 3

    Dutch Rojas on The Soft Nationalization of Healthcare Delivery & Medicine

    While everyone watched the front door for private equity, the house was being dismantled from the inside. The GAO report is clear: More than 50% of physicians are now consolidated with hospital systems. Private equity? 6.5%. The real predator isn't on Wall Street. It's the massive nonprofit complex right down the street. This episode prosecutes the case against university health system consolidation, what The Rojas Report calls "soft nationalization": the absorption of private medicine by entities so heavily subsidized by the state, so protected by tax exemptions, and so entangled with government funding that they function as an arm of the state. IN THIS EPISODE: → The crime scene statistics: 30% consolidated in 2012 to 47% in 2024 → Why private equity is the convenient villain while nonprofits absorb half the profession → The $28 billion annual tax subsidy funding the takeover → Facility fees: how the same service costs 2x more after acquisition → Five economic frameworks explaining why this feels morally wrong → Ghost agencies moving $381 million with zero employees → The verdict for physicians staring at that contract on their desk The pattern is repeating in Oklahoma, New York,  Michigan, Arizona, and Tennessee (All 50 states).  The game is rigged. Knowledge is the only defense. 60,000+ physicians and healthcare operators read The Rojas Report daily. Join them: dutchrojas.substack.com Support the show If you want to support these efforts, Buy Dutch a Cigar, connect via socials, or collaborate, visit: 👉 Stan.Store/DutchRojas

    19 min
  3. JAN 31

    Dutch Rojas on The Hidden Yield Debate: Does Venture Capital Value Extend Beyond IRR?

    As you may know, Dutch Rojas is the co-founder of The Physicians Capital Fund (PhyCap).  PhyCap is a physician-led venture fund that invests in healthcare startups.  All General Partners, except Dutch, are practicing physicians.   He is hosting this debate today to provide additional value and exposure for tech and venture to his physician audience.  Should venture capital be evaluated solely on financial returns, or is there a "hidden yield" that creates equal or greater value for physician investors? In this episode, we debate the core tension every physician capital allocator eventually faces: Are we deploying capital to generate wealth, or are we buying professional sophistication? Can both be true? POSITION A: THE SYNTHESIS VIEW Financial returns are the floor, not the ceiling. Venture capital delivers value on two tracks: capital appreciation and professional development. The non-financial returns — information asymmetry, network density, clinical credibility — compound independently and create strategic advantages traditional asset classes cannot replicate. POSITION B: THE FIDUCIARY VIEW You can't pay a mortgage with insight. Venture capital is a high-risk, illiquid asset class. The fiduciary obligation to generate returns is the whole game. Pattern recognition and conversations are great, but they must translate to hard financial exits. Hidden yield is often marketing language for underperformance. TOPICS COVERED: Information asymmetry: Does 24-36 month forward visibility into healthcare innovation have real value?Network effects: Is relationship density worth the management fees, or is it a glorified LinkedIn group?Clinical diligence: Should physicians care about helping fund managers do their job?Illiquidity: Is the 8-12 year hold period a bug or a feature for physician career trajectories?The compounding flywheel: Does early visibility actually lead to better practice decisions?THE QUESTION WE LEAVE YOU WITH: Are you content with the spreadsheet view, or do you want to leverage your clinical edge? "If this debate resonated, subscribe to the PhyCap Substack for weekly investment thesis analysis. About Physicians Capital Fund:  PhyCap invests $150K-$500K in Seed and Series A healthcare ventures focused on Clinical Care Delivery Workflow Optimization, Software as a Medical Device, and Women's Health. Website: PhyCapFund.com  Substack: PhyCapFund.substack.com  LinkedIn: linkedin.com/company/phycap Support the show If you want to support these efforts, Buy Dutch a Cigar, connect via socials, or collaborate, visit: 👉 Stan.Store/DutchRojas

    17 min
  4. JAN 29

    $33 Million for Running a "Charity": The SERP Loophole Exposed

    Howard Kern retired from Sentara Healthcare in 2021. His payout: $33.2 million. Sentara is a nonprofit. Tax-exempt. A charity. How does a charity write a $33 million check to its CEO? A financial instrument called a SERP. A Supplemental Executive Retirement Plan. Your 401(k) limit: $23,000. Executive SERP limit: None. This episode breaks down the forensic accounting of nonprofit hospital executive compensation: THE MECHANISM: How SERPs let tax-exempt hospitals stockpile unlimited retirement funds for executives while regular employees hit IRS caps. THE CONSULTANTS: SullivanCotter, Pearl Meyer, Gallagher. Three firms that create an upward-only benchmarking spiral. Every board aims for the 75th percentile. The spiral only moves up. THE NONPROFIT PREMIUM: Maurice Smith at HCSC made $34.4 million. Andrew Witty at UnitedHealth made $26.3 million. The nonprofit CEO out-earned the for-profit CEO. With no shareholders. No accountability. THE FAIR SHARE DEFICIT: $37.4 billion in tax exemptions. 2.3% spent on charity care. Kaiser Permanente alone has a $2.5 billion deficit. THE PROTECTION RACKET: The AHA spent $29 million on lobbying in 2024. 55% of their lobbyists are former government officials. This is Form 990 data. Names. Dollar amounts. Receipts. Based on the "Good at Business" series from The Rojas Report. Read the full investigation: dutchrojas.substack.com Support the show If you want to support these efforts, Buy Dutch a Cigar, connect via socials, or collaborate, visit: 👉 Stan.Store/DutchRojas

    18 min
  5. JAN 28

    $480,000: The Annual Tax You Pay, But Can Get Back...

    You're staring at your 2025 P&L. Revenue flat. Expenses up 8-15% across the board. The profit margin that feeds your family is physically smaller than three years ago. The consulting class says run a tighter ship. Cut the bagels. Code better. That advice is a lie. You cannot efficiency your way out of a structural disadvantage. This episode dissects the MedMerge Investment Thesis and breaks down the financial physics crushing independent medicine. A 50-person practice pays $480,000 more per year than an identical facility inside a hospital system. Same coverage. Same carrier. Same risk profile. The only difference is size. That's not a market inefficiency. That's engineered economic pressure designed to drive consolidation. IN THIS EPISODE: The invisible tax: why being small costs you $480,000 annually in insurance aloneThe PE trap: what really happens after the Patagonia vest shows up with a checkThe four-step playbook that turns practice owners into employeesThe goose and the grain silo: infrastructure aggregation without ownership surrenderCaptive insurance and the float: the Warren Buffett parallel that changes everythingPilot results: 85% reduction in Rx spend, $1.4 million returned to physicians in year oneEconomic gravity: why leaving costs $1 million+ (and why you won't want to)The thesis argues you're currently funding your own demise. Every premium check hands carriers the capital they use to build their wealth while your margins shrink. There's a third path. Not PE. Not hospital employment. Infrastructure coordination that makes independent practices unbuyable. LINKS 📰 Read The Rojas Report: https://therojasreport.substack.com 🔗 Connect with Dutch: X: https://x.com/DutchRojasLinkedIn: https://linkedin.com/in/dutchrojas EPISODE KEYWORDS/TAGS independent medical practice, physician independence, private equity healthcare, captive insurance, healthcare economics, practice management, MedMerge, insurance float, healthcare consolidation, physician entrepreneurs 60,000+ physicians and healthcare operators read The Rojas Report daily. Join them. Support the show If you want to support these efforts, Buy Dutch a Cigar, connect via socials, or collaborate, visit: 👉 Stan.Store/DutchRojas

    33 min
  6. JAN 27

    The $12.5 Million Exposed: How Doctors Rent Their Risk While Hospitals Own It

    A $12.5 billion industry. One million physicians paying in. And a wealth transfer hiding in plain sight. In this episode, we break down the malpractice insurance market and expose the financial structure that separates the renters from the owners. The data: Berkshire Hathaway collects $2.2 billion annually from physicians who treat insurance as an expense. Meanwhile, 75% of hospitals run their own captive insurance companies and keep the profits. The math is simple. A high-risk specialist paying $100,000/year in premiums over a 32-year career hands over $3.2 million. In the commercial model, they retire with zero equity. In the captive model, that same money compounds to $12.5 million. Same premiums. Same career. One structure builds generational wealth. The other builds someone else's. We cover: Why only 7 states mandate malpractice insurance (but 95% of doctors carry it anyway)The "going bare" physicians and how they structure around liabilityHow hospitals turned a cost center into a profit centerThe 548,000 private practice physicians sitting on $6.9 billion in addressable opportunityWhy consolidation is accelerating the wealth transfer away from independent medicineThe emerging platforms lowering barriers to physician-owned captivesThe full written investigation with the complete data breakdown:   DutchRojas.Substack.com  Support the show If you want to support these efforts, Buy Dutch a Cigar, connect via socials, or collaborate, visit: 👉 Stan.Store/DutchRojas

    17 min

Ratings & Reviews

5
out of 5
4 Ratings

About

The Rojas Report with Dutch Rojas cuts through the noise in American healthcare. From policy fights in Washington to the boardrooms of venture-backed startups, Dutch brings physicians, investors, and entrepreneurs into real conversations about money, power, and independence in medicine.Expect sharp takes on healthcare policy, candid talks with startup founders, and even the occasional cigar-fueled debate about where the system is headed next.If you care about the future of healthcare, and who really gets to shape it, this is your show.